For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
Selectivity Differences in Size-Exclusion Chromatography for Monoclonal Antibodies; How Pore Size Effects Retention (TN-1251)
The scope of this study is to demonstrate the selectivity differences that can be observed when working with column packing media of different pore sizes. The bioZen SEC-2 media has a 150Å pore and is typically recommended for the separation of smaller mAbs and antibody fragments. The bioZen SEC-3 contains a 300Å pore size that is better for separation of mAb aggregates from monomer. This technote will present the results from this study using two well-characterized mAbs, rituximab and trastuzumab.
Selectivity Differences in Size-Exclusion Chromatography for Monoclonal Antibodies; How Pore Size Effects Retention (TN-1251)
The scope of this study is to demonstrate the selectivity differences that can be observed when working with column packing media of different pore sizes. The bioZen SEC-2 media has a 150Å pore and is typically recommended for the separation of smaller mAbs and antibody fragments. The bioZen SEC-3 contains a 300Å pore size that is better for separation of mAb aggregates from monomer. This technote will present the results from this study using two well-characterized mAbs, rituximab and trastuzumab.
Document Type:
Technical Notes
Techniques:
Separation Modes:
Size Exclusion